drugset / Trial / NCT04239339

Serotonergic Modulation of Cognition, Emotion and Brain Activation in Healthy Volunteers

NCT04239339

RandomizedParallel-groupTriple-blindBasic science

Summary

The aim of this project is: * To apply a pharmacological tool of selective serotonin (5-hydroxytryptamine, 5-HT system) reuptake inhibition in healthy humans. Specifically: * To investigate how sub-chronic administration of 20 mg of escitalopram affects cognitive performance ('cold' cognition) and social-emotional functioning ('hot' cognition) compared with placebo; and * To investigate how sub-chronic administration of 20 mg of escitalopram affects functional brain activation during a paradigm of reinforcement learning following drug administration compared with placebo, and how activation relates to cognitive performance and social-emotional functioning.

Timeline

Start
2020-04-28
Primary completion
2022-10-30
Completion
2022-10-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg

Indications

No indication recorded.